Cargando…

Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines

11β-Hydroxysteroid dehydrogenases (11beta-HSD) modulate mineralocorticoid receptor transactivation by glucocorticoids and regulate access to the glucocorticoid receptor. The isozyme 11beta-HSD2 is selectively expressed in mineralocorticoid target tissues and its activity is reduced in various diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrieu, Thomas, Fustier, Pierre, Alikhani-Koupaei, Rasoul, Ignatova, Irena D., Guettinger, Andreas, Frey, Felix J., Frey, Brigitte M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136812/
https://www.ncbi.nlm.nih.gov/pubmed/25133511
http://dx.doi.org/10.1371/journal.pone.0105354
_version_ 1782331029442265088
author Andrieu, Thomas
Fustier, Pierre
Alikhani-Koupaei, Rasoul
Ignatova, Irena D.
Guettinger, Andreas
Frey, Felix J.
Frey, Brigitte M.
author_facet Andrieu, Thomas
Fustier, Pierre
Alikhani-Koupaei, Rasoul
Ignatova, Irena D.
Guettinger, Andreas
Frey, Felix J.
Frey, Brigitte M.
author_sort Andrieu, Thomas
collection PubMed
description 11β-Hydroxysteroid dehydrogenases (11beta-HSD) modulate mineralocorticoid receptor transactivation by glucocorticoids and regulate access to the glucocorticoid receptor. The isozyme 11beta-HSD2 is selectively expressed in mineralocorticoid target tissues and its activity is reduced in various disease states with abnormal sodium retention and hypertension, including the apparent mineralocorticoid excess. As 50% of patients with essential hypertension are insulin resistant and hyperinsulinemic, we hypothesized that insulin downregulates the 11beta-HSD2 activity. In the present study we show that insulin reduced the 11beta-HSD2 activity in cancer colon cell lines (HCT116, SW620 and HT-29) at the transcriptional level, in a time and dose dependent manner. The downregulation was reversible and required new protein synthesis. Pathway analysis using mRNA profiling revealed that insulin treatment modified the expression of the transcription factor family C/EBPs (CCAAT/enhancer-binding proteins) but also of glycolysis related enzymes. Western blot and real time PCR confirmed an upregulation of C/EBP beta isoforms (LAP and LIP) with a more pronounced increase in the inhibitory isoform LIP. EMSA and reporter gene assays demonstrated the role of C/EBP beta isoforms in HSD11B2 gene expression regulation. In addition, secretion of lactate, a byproduct of glycolysis, was shown to mediate insulin-dependent HSD11B2 downregulation. In summary, we demonstrate that insulin downregulates HSD11B2 through increased LIP expression and augmented lactate secretion. Such mechanisms are of interest and potential significance for sodium reabsorption in the colon.
format Online
Article
Text
id pubmed-4136812
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41368122014-08-20 Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines Andrieu, Thomas Fustier, Pierre Alikhani-Koupaei, Rasoul Ignatova, Irena D. Guettinger, Andreas Frey, Felix J. Frey, Brigitte M. PLoS One Research Article 11β-Hydroxysteroid dehydrogenases (11beta-HSD) modulate mineralocorticoid receptor transactivation by glucocorticoids and regulate access to the glucocorticoid receptor. The isozyme 11beta-HSD2 is selectively expressed in mineralocorticoid target tissues and its activity is reduced in various disease states with abnormal sodium retention and hypertension, including the apparent mineralocorticoid excess. As 50% of patients with essential hypertension are insulin resistant and hyperinsulinemic, we hypothesized that insulin downregulates the 11beta-HSD2 activity. In the present study we show that insulin reduced the 11beta-HSD2 activity in cancer colon cell lines (HCT116, SW620 and HT-29) at the transcriptional level, in a time and dose dependent manner. The downregulation was reversible and required new protein synthesis. Pathway analysis using mRNA profiling revealed that insulin treatment modified the expression of the transcription factor family C/EBPs (CCAAT/enhancer-binding proteins) but also of glycolysis related enzymes. Western blot and real time PCR confirmed an upregulation of C/EBP beta isoforms (LAP and LIP) with a more pronounced increase in the inhibitory isoform LIP. EMSA and reporter gene assays demonstrated the role of C/EBP beta isoforms in HSD11B2 gene expression regulation. In addition, secretion of lactate, a byproduct of glycolysis, was shown to mediate insulin-dependent HSD11B2 downregulation. In summary, we demonstrate that insulin downregulates HSD11B2 through increased LIP expression and augmented lactate secretion. Such mechanisms are of interest and potential significance for sodium reabsorption in the colon. Public Library of Science 2014-08-18 /pmc/articles/PMC4136812/ /pubmed/25133511 http://dx.doi.org/10.1371/journal.pone.0105354 Text en © 2014 Andrieu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Andrieu, Thomas
Fustier, Pierre
Alikhani-Koupaei, Rasoul
Ignatova, Irena D.
Guettinger, Andreas
Frey, Felix J.
Frey, Brigitte M.
Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines
title Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines
title_full Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines
title_fullStr Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines
title_full_unstemmed Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines
title_short Insulin, CCAAT/Enhancer-Binding Proteins and Lactate Regulate the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Colon Cancer Cell Lines
title_sort insulin, ccaat/enhancer-binding proteins and lactate regulate the human 11β-hydroxysteroid dehydrogenase type 2 gene expression in colon cancer cell lines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136812/
https://www.ncbi.nlm.nih.gov/pubmed/25133511
http://dx.doi.org/10.1371/journal.pone.0105354
work_keys_str_mv AT andrieuthomas insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines
AT fustierpierre insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines
AT alikhanikoupaeirasoul insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines
AT ignatovairenad insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines
AT guettingerandreas insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines
AT freyfelixj insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines
AT freybrigittem insulinccaatenhancerbindingproteinsandlactateregulatethehuman11bhydroxysteroiddehydrogenasetype2geneexpressionincoloncancercelllines